ORCA
Online Research @ Cardiff
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 4.
McPhail, Darius K., Alzahrani, Mohammad A.M., Martin, Katie R., Calver, Brian L., Harwood, Adrian J.  ORCID: https://orcid.org/0000-0003-3124-5169, MacKeigan, Jeffrey P., Davies, David M. and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631
2025.
Loss of tuberous sclerosis complex 2 confers inflammation via dysregulation of nuclear factor kappa-light-chain-enhancer of activated B cells.
Journal of Inflammation
22
(1)
, 38.
10.1186/s12950-025-00464-8
|
|
|
Tahsin, Tasmia, McPhail, Darius K., Champion, Jesse D., Alzahrani, Mohammad A. M., Hilditch, Madeleine L., Faris-Orr, Alexandre, Calver, Brian L., Cronin, James G., Mareque-Rivas, Juan C., Sexton, Darren W., Hughes, Stephen Fôn, Conlan, Robert Steven, Davies, David Mark and Tee, Andrew R.
2025.
Targeting NRF2 and FSP1 to overcome ferroptosis resistance in TSC2-deficient and cancer cells.
Cancers
17
(16)
, 2714.
10.3390/cancers17162714
|
|
|
|
Alzahrani, Mohammad
2023.
Delineating the signalling interplay between mTORC1 and MET in Tuberous Sclerosis Complex.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
|
|
Champion, Jesse D., Dodd, Kayleigh M., Lam, Hilaire C., Alzahrani, Mohammad A.M., Seifan, Sara, Rad, Ellie, Scourfield, David Oliver, Fishel, Melissa L., Calver, Brian L., Ager, Ann ORCID: https://orcid.org/0000-0002-5763-8908, Henske, Elizabeth P., Davies, D. Mark, Kelley, Mark R. and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631
2022.
Drug inhibition of redox factor-1 restores hypoxia-driven changes in tuberous sclerosis complex 2 deficient cells.
Cancers
14
(24)
, 6195.
10.3390/cancers14246195
|
|
|